Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Alpinetin helps grow hair by turning on hair stem cells and is safe for use.

JAK inhibitors are effective for long-term management of alopecia areata.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.